To access this element change to forms mode OFF
Grant Award View - GA201588
A personalised pharmacogenomic approach to inform autosomal dominant...
GA ID:
GA201588
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$650,740.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
A personalised pharmacogenomic approach to inform autosomal dominant hypocalcaemia treatment
Purpose:
Autosomal dominant hypocalcemia (ADH) is a rare disorder caused by genetic mutations that disrupt the body’s ability to retain calcium. There is no treatment for ADH. Developing new therapies has been difficult as potential drugs behave differently depending on the underlying mutation. My research is characterising how mutations in ADH can change drug behaviour. I am using this information to design new therapies resistant to these effects, providing treatment options for ADH sufferers.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2008341
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA